In this paper, we report bidirectional negative differential resistance (NDR) in Al(Ga)N/GaN/AlN resonant tunneling diodes grown on free-standing GaN substrates by RF-plasma assisted molecular beam epitaxy. Bidirectional NDR has exhibited a current–voltage (I–V) characteristic in both forward and reverse biases at room temperature. The positive peak current density is 160 kA/cm2 with a peak to valley current ratio (PVCR) of 1.34, and the negative peak current density is 112 kA/cm2 with a high PVCR of 1.56. The bidirectional NDR is attributed to the change in the polarization field in the active region, which is caused by the asymmetric barrier component.
High Al-content AlGaN epilayers were grown on AlN template by using indium (In) surfactant with plasma-assisted molecular beam epitaxy (PA-MBE), and deep ultraviolet emission at 235 nm was obtained at room temperature. The effects and mechanisms of In-surfactant on the crystalline quality and optical properties of AlGaN were investigated. It was found that In-surfactant could facilitate two-dimensional AlGaN growth by reducing activation barrier for Al/Ga atoms to cross steps and effectively increasing the migration rate on the growth surface, and thus improve surface morphology and decrease defect density. The photoluminescence measurements revealed that the optical properties were remarkably improved by adopting In as surfactant, and phase separation was also effectively eliminated. Furthermore, the concentration of impurities including oxygen and silicon was decreased, which is attributed to higher defects formation energy for these impurities with In-surfactant assisted epitaxy growth.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.